Home / Intelligence /

Search

Briefs

2025 Annual State of Learning & Development in Life Sciences

Through the 2020s, life sciences leaders have dealt with one challenge after another. The shock of the COVID-19 pandemic. Sticky inflation. Return-to-office mandates. The intense pressure to perform in the face of disruptive challenges has proven constant. For commercial learning and development, also known as commercial L&D, this has presented new roadblocks and innovations alike, making data more important than ever to navigate a rapidly changing industry. That’s why TGaS Advisors, a Division of Trinity Life Sciences, in partnership with…

Read Now

Briefs

Leading the Evolution: Navigating AI and Pharma Market Trends

How are Commercial, Medical and Market Access organizations evolving to develop capabilities and accelerate innovation in 2025 and beyond? Executive leaders are focused on making informed organizational decisions to propel the evolution of capabilities in this rapidly changing global economy. As you strategize to optimize structure, talent and capabilities to excel in the future, this Advisory Brief brings you critical insights gleaned from the recent TGaS Advisors’ 2025 Spring Summit. Complete the form below to access the advisory brief. By submitting this form,…

Read Now

Blog

Is Medical Omnichannel Poised for Growth?

Published December 10, 2024

79% of respondents are predicting an increase in spend in Omnichannel capabilities for Medical Affairs in 2025, according to a recent TGaS survey fielded in September 2024.* This predicted increase for Medical Omnichannel indicates that there is a real need to find ways to inform, educate and engage HCPs beyond the traditional in-person channel.    What is Medical Omnichannel?  Medical omnichannel is an orchestrated approach to scientific engagement, leveraging analytics and insights to optimize educational content and channels in a customer-centric…

Read Now

Briefs

2024 Annual Digital Marketing Competency Report

Trinity Life Sciences, a leader in global life sciences commercialization solutions, released its third annual TGaS Digital Marketing Competency Report assessing 150+ biopharma brands through the lens of digital marketing patient/caregiver experiences. The study evaluates the brands across five categories and more than 100 characteristics to understand each one’s digital marketing presence and establish a brand digital competency ranking.  Learn what sets some brands apart from others. To download the excerpt of the report with the ranking of all 150+…

Read Now

Briefs

A Pharma Operations Lens on Commercial and Medical IT Project Support

Improving partnerships is a crucial aspect of successful organizations. However, many companies face challenges in aligning their Commercial Operations and Information Technology teams. These conflicts often lead to inefficiencies in processes, resources and functionality, which ultimately impact the overall capabilities of the organization. To address these challenges, companies have implemented various strategies to enhance collaboration and alignment. Our observation suggests that the key to resolving these issues lies in fostering strong relationships between the teams. During our conversations with industry…

Read Now

Briefs

What You Need to Know Now to Be Prepared for 2024

Highlights from TGaS Advisors’ Fall Summit How are Biopharmaceutical organizations evolving to develop capabilities and propel innovation for 2024 and beyond? Executive leaders in Commercial Operations, Medical Affairs and Market Access are focused on making informed decisions to propel the evolution of their organizations in this rapidly changing global economy. As you strategize to accelerate optimizing structure, talent and capabilities to excel in the future, this Advisory Brief brings you critical insights gleaned from the recent TGaS Advisors’ Fall Summit.…

Read Now

White Papers

The Globalization Marathon: Is Pharma Commercial Operations Moving to a Full Global Operating Model?

In the pharmaceutical industry, there has been ongoing discussion whether the Commercial Operations departments should become a globalized function. Over the past decade as companies have become more global in commercializing their products, organizations have been investigating the effectiveness of the Commercial Operations ecosystem. For 20 years, TGaS Advisors, a Division of Trinity Life Sciences, has been working with U.S. Commercial Operations leaders in the pharmaceutical industry, providing benchmarks and insights across 9 capability areas/departments and over 50 unique functions.…

Read Now

White Papers

TGaS Annual MarTech and AdTech Landscape

Navigating the MarTech Jungle: An Analysis of The Technology Powering 160+ Pharma Brands. In today’s hyperconnected digital landscape, the marketing technology (MarTech) space has exploded into a complex ecosystem of over 10,000 potential vendors and services. The sheer volume of available options presents opportunities for pharmaceutical brands to optimize their performance and gain a competitive advantage. In this white paper, TGaS has meticulously reviewed the technology powering 160+ patient websites to understand which tools are leading in their respective categories…

Read Now

Briefs

Leading the Evolution in Commercial Operations

This advisory brief incorporates learnings from TGaS Advisors’ 2023 Spring Summit, which brought together the industry’s top commercial operations, market access and medical affairs executives to discuss the hottest trends, address concerns and prepare for future challenges. Leaders from more than 100 emerging, mid tier and large tier biopharmaceutical companies attended function specific sessions. Leaders shared perspectives, made recommendations and collectively thought through alternative paths for key decisions for today and beyond. Complete the form below to access the full…

Read Now

White Papers

Integrated Delivery Networks (IDNs)

Pharmaceutical companies that are seeking ways to engage and partner with integrated delivery networks must understand this: IDNs are evolving in ways that have a profound effect on how healthcare is managed, what care paths are followed and which populations are carved out for special attention. TGaS Advisors, a division of Trinity Life Sciences, conducted 15 in-depth interviews with key decision-makers from advanced healthcare systems in the U.S. to understand their perspectives on what is driving IDNs and what they…

Read Now